TNFα-induced cyclooxygenase 2 not only increases the vasopermeability of blood-brain barrier but also enhances the neutrophil survival in Escherichia coli-induced brain inflammation

Prostaglandins and Other Lipid Mediators

Volumn 57, Issue 5-6, 1999, Pages 371-382

  Tsao, Nina ^a   Hsu, Hui Ping ^a   Lei, Huan Yao ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Blood brain barrier; Cox 2; TNF

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; TUMOR NECROSIS FACTOR ALPHA; ISOENZYME; N-(2-CYCLOHEXYLOXY-4-NITROPHENYL)METHANESULFONAMIDE; NITROBENZENE DERIVATIVE; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; SULFONAMIDE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; CELL INFILTRATION; CELL VIABILITY; CONTROLLED STUDY; ENCEPHALITIS; ENZYME ACTIVITY; ESCHERICHIA COLI; IMMUNOHISTOCHEMISTRY; MOUSE; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; SEPSIS; ANIMAL; APOPTOSIS; BIOSYNTHESIS; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; ENTEROBACTER INFECTION; ENZYME INDUCTION; ENZYMOLOGY; PATHOLOGY;

ANIMALS; APOPTOSIS; BLOOD-BRAIN BARRIER; CELL SURVIVAL; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; ENCEPHALITIS; ENZYME INDUCTION; ESCHERICHIA COLI INFECTIONS; ISOENZYMES; MICE; NEUTROPHILS; NITROBENZENES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SULFONAMIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032587739     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(99)00013-1     Document Type: Article

References (28)

1. Mitchell J.A., Larkin S., Williams T.J. Cyclooxygenase-2 regulation and relevance in inflammation . Biochem Pharmacol. 50:1995;1535-1542.
2. Dubois R.N., Abramson S.B., Crofford L., et al. Cyclooxygenase in biology and disease. FASEB J. 12:1998;1063-1073.
3. Vanfurth A.M., Roord J.J., Vanfurth R. Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy. Infect Immunol. 64:1996;4883-4890.
4. Perry V.H., Anthony D.C., Bolton S.J., Brown H.C. The blood-brain barrier and the inflammatory response. Mol Med Today. 3:1997;335-341.
5. Kim K.S., Wass C.A., Cross A.S. Blood-brain barrier permeability during the development of experimental bacterial meningitis in the rat. Exp Neurol. 145:1997;253-257.
6. Sharief M.K., Ciardi M., Thompson E.J. Blood-brain barrier damage in patients with bacterial meningitis association with tumor necrosis factor-α but not interleukin-1β J Infect Dis. 166:1992;350-358.
7. Saukkoneu K., Sande S., Cioffe C., et al. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J Exp Med. 171:1990;439-448.
8. Quagliarello V.J., Wispelwey B., Long W.J. Jr, Scheld W.M. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J Clin Invest. 87:1991;1360-1366.
9. Ho T.S., Tsai C.Y., Tsao N., Chow N.H., Lei H.Y. Infiltrated cells in experimental allergic encephalomyelitis by additional intracerebral injection in myelin-basic-protein-sensitized B6 mice. J Biomed Sci. 4:1997;300-307.
10. - exchanger in spontaneous thymocyte apoptosis. J Immunol. 157:1996;1107-1116.
11. Janzer R.C., Raff M.C. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature. 325:1987;253-257.
12. Abbott N.J., Romero I.A. Transporting therapeutics across the blood-brain barrier. Mol Med Today. 2:1996;106-113.
13. Ramilo O., Saez-Llorens X., Mertsola J., et al. Tumor necrosis factor α/cachectin and interleukin 1β initiate meningeal inflammation. J Exp Med. 172:1990;497-507.
14. Waage A., Halstensen A., Shalaby R., et al. Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J Exp Med. 170:1989;1859-1867.
15. O'banion M.K., Miller J.C., Chang J.W., Kaplan M.D., Coleman P.D. Interleukin-1 beta induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures. J Neurochem. 66:1996;2532-2540.
16. Burch R.M., Tiffany C.W. Tumor necrosis factor causes amplification of arachidonic acid metabolism in response to interleukin 1, bradykinin, and other agonists. J Cell Physiol. 141:1989;85-89.
17. Niiro H., Otsuka T., Izuhara K., et al. Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils. Blood. 89:1997;1621-1628.
18. Maloney C.G., Kutchera W.A., Albertine K.H., Mcintyre T.M., Prescott S.M., Zimmerman G.A. Inflammatory agonists induce cyclooxygenase type 2 expression by human neutrophils. J Immunol. 160:1998;1402-1410.
19. Pouliot M., Gilbert C., Borgeat P., et al. Expression and activity of prostaglandin endoperoxide synthase-2 in agonist-activated human neutrophils. FASEB J. 12:1998;1109-1123.
20. Vane J.R., Mitchell J.A., Appleton I., et al. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci USA. 91:1994;2046-2050.
21. Appleton I., Tomlinson A., Mitchell J.A., Willoughby D.A. Distribution of cyclooxygenase isoforms in murine chronic granulomatous inflammation. Implications for future anti-inflammatory therapy. J Pathol. 176:1995;413-420.
22. Smalley W.E., Dubois R.N. Colorectal cancer and nonsteroidal anti-inflammatory drugs. Adv Pharmacol. 39:1997;1-20.
23. Oshima M., Dinchuk J.E., Kargman S.L., et al. Suppression of intestinal polyposis in Apc delta 716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 87:1996;803-809.
24. Tsujii M., Dubois R.N. Alteration in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell. 83:1995;493-501.
25. Lu X., Xie W., Reed D., Bradshaw W.S., Simmons D.L. Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts. Proc Natl Acad Sci USA. 92:1995;7961-7965.
26. Sheng H., Shao J., Morrow J., Beauchamp R.D., Dubois R.N. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res. 58:1998;362-366.
27. Kawamori T., Rao C.V., Seibert K., Reddy B.S. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res. 58:1998;409-412.
28. Rossi A.G., Cousin J.M., Dransfield I., Lawson M.F., Chilvers E.R., Haslett C. Agents that elevate cAMP inhibit human neutrophil apoptosis. Biochem Biophys Res Commun. 217:1995;892-899.